8-K: SRAX, Inc. Secures $75,000 in Funding Through Convertible Promissory Note

SRAX, Inc. has entered into a securities purchase agreement for a $90,000 convertible promissory note, with an original issue discount, resulting in $75,000 in funding.

Summary

• SRAX, Inc. has issued a convertible promissory note with a principal amount of $90,000, which was sold for $75,000, representing a 20% original issue discount.
• The note matures on March 29, 2026, and does not accrue interest.
• The note is convertible into shares of SRAX's Class A common stock at an initial conversion price of $0.25 per share.
• The conversion price is subject to adjustments for stock splits, dividends, rights offerings, pro-rata distributions, and certain fundamental transactions.
• SRAX has the option to prepay the note with a 120% premium within the first 90 days, or 135% premium after 90 days.
• The agreement includes standard default provisions, such as non-payment of principal and changes in company control, which could trigger immediate payment of the outstanding principal plus liquidated damages.
• The offering was conducted as a private placement, exempt from registration under the Securities Act of 1933.

Sentiment

Score: 6

Explanation: The document indicates a necessary capital raise, but the terms of the note are not particularly favorable for the company, with a high discount and potential dilution. The lack of interest payments is a positive for the company, but the high prepayment premiums are a negative.

Positives

• SRAX has successfully raised $75,000 in capital.
• The convertible note structure provides flexibility for both the company and the investor.
• The prepayment option allows SRAX to manage its debt obligations.

Negatives

• The 20% original issue discount means SRAX received less cash than the face value of the debt.
• The note does not accrue interest, which may be less attractive to some investors.
• The conversion of the note could dilute existing shareholders.
• The prepayment premium of 120% or 135% could be costly if SRAX chooses to prepay the note.

Risks

• The conversion of the note could dilute existing shareholders.
• Failure to meet the terms of the note could trigger an event of default, leading to accelerated repayment and potential penalties.
• The company's ability to repay the note or manage its debt obligations is dependent on its future financial performance.
• The company may need to raise additional capital in the future, which could further dilute existing shareholders or increase debt.

Future Outlook

The company may need to manage potential dilution from the conversion of the note and ensure compliance with the terms of the agreement to avoid default.

Management Comments

• The company has not provided any specific management comments in this document.

Industry Context

This type of financing is common for smaller companies seeking capital, especially those that may not have access to traditional bank loans. The convertible note structure is often used to attract investors who are willing to take on more risk in exchange for potential upside through equity conversion.

Comparison to Industry Standards

• The 20% original issue discount is relatively high, suggesting the company may have had limited negotiating power or that the investor perceived a higher risk.
• The conversion price of $0.25 per share will be compared to the market price of the stock at the time of conversion to determine the value of the conversion option.
• The prepayment premiums of 120% and 135% are within the typical range for convertible notes, but the specific terms will be compared to similar deals to assess their favorability.
• The lack of interest payments is unusual for debt instruments and may indicate a higher risk profile for the company.

Stakeholder Impact

• Shareholders may experience dilution if the note is converted into common stock.
• Creditors may be impacted by the terms of the note, particularly if an event of default occurs.
• Employees may be affected by the company's financial performance and ability to meet its obligations.

Next Steps

• SRAX needs to manage the potential dilution from the conversion of the note.
• SRAX needs to ensure compliance with the terms of the agreement to avoid default.
• SRAX needs to monitor the market price of its stock to assess the potential impact of the conversion option.

Key Dates

Keywords

convertible note, promissory note, funding, private placement, original issue discount, conversion price, common stock, securities purchase agreement, debt financing, SRAX